Acromegaly Treatment Market Size, Share & Trends Analysis Report By Product (Somatostatin analogs, GHRA), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2019 - 2025

Table of Contents

Chapter 1 Report Scope
                  1.1 Segment Market Scope
                  1.2 Regional Scope
                  1.3 Estimates & Forecast Timeline
Chapter 2 Research Methodology
                  2.1 Model Details
                      2.1.1 Regression and variable analysis
                  2.2 Information Procurement
                  2.3 List Of Primary Sources
                      2.3.1 Purchased database:
                      2.3.2 GVR’s internal database
                  2.4 Primary Interview Breakup
                      2.4.1 Data for primary interviews, by sources
                      2.4.2 Data for primary interviews, by region
                  2.5 List Of Secondary Sources
Chapter 3 Report Objectives
                  3.1 Objectives
Chapter 4 Executive Summary
                  4.1 Market Summary
Chapter 5 Market Definitions
                  5.1 Definitions
Chapter 6 Acromegaly Treatment market: Industry Outlook
                  6.1 Market Variable Analysis
                  6.2 Market Driver Analysis
                      6.2.1 Increasing prevalence of acromegaly
                      6.2.3 Ongoing clinical trials
                  6.3 Market Restraints Analysis
                      6.3.1 High treatment cost
                      6.3.2 Lack of awareness among people
                  6.4 Business Environment Analysis Tools
                      6.4.1 Acromegaly Treatment market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                      6.4.2 Porter’s Five Forces Analysis
Chapter 7 Regulatory & Political Forces
                  7.1 Regulatory Landscape
                      7.1.1 List of regulations, by country
                      7.1.2 North America
                      7.1.4 Europe
                      7.1.5 Asia Pacific
                      7.1.7 Latin America
                      7.1.9 MEA
                  7.2 Political Landscape, Current & Future Scenario
Chapter 8 Competitive & Vendor Landscape
                  8.1 Market Participation Categorization
                      8.1.1 Market leader
                      8.1.2 Innovators
                  8.2 Strategic Initiatives & Outcome Analysis
                  8.3 List of Key Companies, By Product
                  8.4 Company Market Share Analysis
                      8.4.1 Acromegaly treatment market company market share analysis, 2017
Chapter 9 Acromegaly Treatment Market: Product Analysis
                  9.1 Product Business Analysis
                  9.2 Somatostatin analogs (SSA)
                      9.2.1 Somatostatin analogs (SSA) estimates and forecasts, 2014 - 2025 (USD Million)
                  9.3 GHRA
                      9.3.1 GHRA market estimates and forecasts, 2014 - 2025 (USD Million)
                  9.4 Others
                      9.4.1 others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 10 Acromegaly Treatment market: End Use Analysis
                  10.1 End-Use Business Analysis
                  10.2 Hospitals
                      10.2.1 hospitals estimates and forecasts, 2014 - 2025 (USD Million)
                  10.3 Clinics
                      10.3.1 clinics market estimates and forecasts, 2014 - 2025 (USD Million)
                  10.4 Others
                      10.4.1 others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 11 Acromegaly Treatment Market: Regional Analysis
                  11.1 North America
                      11.1.1 North America Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.1.2 U.S.
                          11.1.2.1 U.S. Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.1.3 Canada
                          11.1.3.1 Canada Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.2 Europe
                      11.2.1 Europe Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.2 Germany
                          11.2.2.1 Germany Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.3 U.K.
                          11.2.3.1 U.K. Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.4 France
                          11.2.4.1 France Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.5 Italy
                          11.2.5.1 Italy Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.2.6 Spain
                          11.2.6.1 Spain Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.3 Asia Pacific
                      11.3.1 Asia Pacific Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.3.2 China
                          11.3.2.1 China Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.3.3 India
                          11.3.3.1 India Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.3.4 Japan
                          11.3.4.1 Japan Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.4 Latin America
                      11.4.1 Latin America Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.4.2 Mexico
                          11.4.2.1 Mexico Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.4.3 Brazil
                          11.4.3.1 Brazil Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                  11.5 MEA
                      11.5.1 MEA Acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
                      11.5.2 South Africa
                          11.5.2.1 South Africa acromegaly treatment market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 12 Company Profiles
                  12.1 Key Company Profiles
                      12.1.1 Novartis AG
                          12.1.1.1 Company overview
                          12.1.1.2 Financial performance
                          12.1.1.3 Product benchmarking
                          12.1.1.4 Strategic initiatives
                      12.1.2 Ipsen Pharma
                          12.1.2.1 Company overview
                          12.1.2.2 Financial performance
                          12.1.2.3 Product benchmarking
                          12.1.2.4 Strategic initiatives
                      12.1.3 SUN PHARMACEUTICAL INDUSTRIES LTD.
                          12.1.3.1 Company overview
                          12.1.3.2 Product benchmarking
                          12.1.3.3 Strategic initiatives
                      12.1.4 Chiasma, Inc.
                          12.1.4.1 Company overview
                          12.1.4.2 Product benchmarking
                          12.1.4.3 Strategic initiatives
                      12.1.5 Peptron, Inc
                          12.1.5.1 Company overview
                          12.1.5.2 Financial Performance
                          12.1.5.3 Product benchmarking
                          12.1.5.4 Strategic initiatives
                      12.1.6 WOCKHARDT
                          12.1.6.1 Company overview
                          12.1.6.2 Financial performance
                          12.1.6.3 Product benchmarking
                          12.1.6.4 Strategic initiatives
                      12.1.7 Dauntless Pharmaceuticals
                          12.1.7.1 Company overview
                          12.1.7.2 Product benchmarking
                          12.1.7.3 Strategic initiatives
                      12.1.8 Pfizer Inc.
                          12.1.8.1 Company overview
                          12.1.8.2 Financial performance
                          12.1.8.3 Product benchmarking
                          12.1.8.4 Strategic initiatives
                      12.1.9 Ionis Pharmaceuticals, Inc.
                          12.1.9.1 Company overview
                          12.1.9.2 Product benchmarking
                          12.1.9.3 Strategic initiatives
Chapter 13 Recommendations/Conclusion
                  13.1 Recommendations
                  13.2 Conclusion

List of Tables

Table 1 Country share estimation
Table 2 List of regulations, by country
Table 3 List of key companies, by product
Table 4 North America acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 5 North America acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 6 U.S. acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 7 U.S. acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 8 Canada acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 9 Canada acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 10 Europe acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 11 Europe acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 12 Germany acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 13 Germany acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 14 U.K. acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 15 U.K. acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 16 Italy acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 17 Italy acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 18 France acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 19 France acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 20 Spain acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 21 Spain acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 22 Asia Pacific acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 23 Asia Pacific acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 24 Asia Pacific acromegaly treatment market, by site, 2014 - 2025 (USD Million)
Table 25 Asia Pacific acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 26 China acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 27 China acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 28 India acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 29 India acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 30 Latin America acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 31 Latin America acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 32 Mexico acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 33 Mexico acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 34 Brazil acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 35 Brazil acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 36 MEA acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 37 MEA acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)
Table 38 South Africa acromegaly treatment market, by product, 2014 - 2025 (USD Million)
Table 39 South Africa acromegaly treatment market, by end-use, 2014 - 2025 (USD Million)

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Value chain-based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Components: TAM
Fig. 6 Information procurement
Fig. 7 Primary interviews, by sources
Fig. 8 Primary interviews, by region
Fig. 9 Acromegaly treatment market revenues, 2017, (USD Millions)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Acromegaly treatment market - SWOT analysis, by the factor (political & legal, economic and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Market participant categorization
Fig. 16 Strategy framework analysis, 2017
Fig. 17 Acromegaly treatment market share, 2017
Fig. 18 Acromegaly treatment market product outlook: Key takeaways
Fig. 19 Acromegaly treatment market: Product movement analysis
Fig. 20 Global somatostatin analog market, 2014 - 2025 (USD Million)
Fig. 21 Global GHRA market, 2014 - 2025 (USD Million)
Fig. 22 Global others market, 2014 - 2025 (USD Million)
Fig. 23 Acromegaly treatment market end-use outlook: Key takeaways
Fig. 24 Acromegaly treatment market: End-Use movement analysis
Fig. 25 Global hospitals & clinics market, 2014 - 2025 (USD Million)
Fig. 26 Global others market, 2014 - 2025 (USD Million)
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 Regional outlook, 2014 - 2025 (USD Million)
Fig. 29 North America Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 30 U.S. Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 31 Canada Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 32 Europe Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 33 Germany Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 34 U.K. Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 35 Italy Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 36 France Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 37 Spain Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 38 Asia Pacific Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 39 China Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 40 India Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 41 Japan Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 42 Latin America Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 43 Mexico Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 44 Brazil Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 45 MEA Acromegaly treatment market, 2014 - 2025 (USD Million)
Fig. 46 South Africa Acromegaly treatment market, 2014 - 2025 (USD Million)